Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study
Clinical trial NCT02844270 · UNKNOWN
Trial details
- NCT number
- NCT02844270
- Sponsor
- Shanghai Bio-heart Biological Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-09
- Primary completion
- 2016-12-22
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.